RESEARCH
Analysis & Insights
Deep dives on small-cap stocks, scoring methodology, sector analysis, and data-driven market research.
Industrials Small-Caps: 2026 Analysis
Top 5 industrials small-caps by score in 2026. Infrastructure, defense, and manufacturing picks with data. Try free for 30 days.
Consumer Small-Caps: Sector Analysis 2026
Top 5 consumer small-caps by fundamental score in 2026. DTC brands, retail innovators ranked by data. Start your free 30-day trial today.
Energy Small-Caps: Sector Analysis 2026
Top 5 energy small-caps by fundamental score in 2026. Oil, gas, and renewables ranked with sector benchmarks. Try free for 30 days.
Best Small-Cap Biotech Stocks 2026
Top 5 small-cap biotech stocks by fundamental score in 2026. Pipeline analysis, cash runway, and risk factors. Try free for 30 days.
Small-Cap Stocks to Watch — April 2026
Five small-cap stocks with the largest fundamental score gains this week. Data-driven picks for April 2026. Try free for 30 days.
What Is a Good Stock Score?
A score above 70/100 places a small-cap in the top 10%. Learn our rating system and what scores really mean. Try free for 30 days.
Revenue Growth: The Key Small-Cap Metric
Revenue growth carries 20% weight in our small-cap scoring model. Learn how we measure it and what good looks like. Try free for 30 days.
Fundamental Analysis for Small-Caps
Step-by-step guide to fundamental analysis on small-cap stocks using 8 metrics. Screen 2,200+ companies — try free for 30 days.
Best Small-Cap Stocks to Watch Q2 2026
The 10 highest-scoring small-cap stocks entering Q2 2026, ranked by our 8-metric fundamental model. Start your free 30-day trial today.
How to Find Undervalued Small-Cap Stocks
A repeatable framework for finding undervalued small-cap stocks using P/S ratio filters and fundamental scoring. Try free for 30 days.
VERI Surges 22% on AI Revenue Outlook
Veritone (VERI) surged 22% on $130-145M revenue guidance. AI data marketplace breakdown. Track VERI and 2,200+ stocks free for 30 days.
BWAY Gets FDA At-Home Device Approval
BrainSway (BWAY) gets FDA clearance for at-home Deep TMS. Revenue impact, TAM analysis, and score breakdown. Try free for 30 days.
LOVE Crushes Q4 — Stock Surges 20%
Lovesac (LOVE) beat Q4 estimates and surged 20%. Revenue, margins, $40M buyback breakdown. Track LOVE and 2,200+ stocks free for 30 days.
How to Read a SmallCap Signal Score
A score of 85 does not mean buy. Learn what SmallCap Signal scores measure and how to use them effectively. Try free for 30 days.
AIRO Group Stock Analysis: Score 91/100
AIRO Group scores 91/100: 101% revenue growth, 67% gross margins, 35% insider ownership. Full analysis — try free for 30 days.
PNRG Stock Analysis: Score 91/100
PrimeEnergy (PNRG) scores 91/100: 65% insider ownership, 90% revenue growth, infinite cash runway. Full analysis — try free for 30 days.
CHA Stock Analysis: Score 92/100
Chagee Holdings (CHA) scores 92/100: 167% revenue growth, 0.15x P/S, $4.75B cash. Full breakdown — start your free 30-day trial today.
Gross Margin: Key Metric for Small-Caps
Gross margin reveals if a small-cap business model works. Sector benchmarks, warning signs, and scoring methodology. Try free for 30 days.
EXOD Stock Analysis: Score 92/100
Exodus Movement (EXOD) scores 92/100: 109% revenue growth, zero debt, 60% insider ownership. Full analysis — try free for 30 days.
Small-Cap ETFs vs Stock Picking
Small-cap ETFs vs individual stock picking: which delivers better returns? A data-driven comparison. Screen 2,200+ stocks free for 30 days.
Tech Small-Caps: 2026 Sector Analysis
Technology small-caps score highest in our 2026 model. Top picks, Rule of 40 analysis, and risk factors. Start your free 30-day trial today.
How to Build a Small-Cap Watchlist
Build a systematic small-cap watchlist: scoring filters, sector balance, and monthly review cadence. Screen 2,200+ stocks free for 30 days.
P/S Ratio: Small-Cap Valuation Guide
The price-to-sales ratio is the best valuation metric for pre-profit small-caps. Sector benchmarks and screening tips. Try free for 30 days.
Top 5 Healthcare Small-Caps 2026
Five healthcare small-caps with scores above 88/100. Revenue growth, margins, and risk analysis for each. Start your free 30-day trial.
Healthcare Small-Caps: 2026 Analysis
Healthcare dominates top-scoring small-caps in 2026. Sub-sector breakdown, top 5 picks, and key metrics. Start your free 30-day trial today.
Top 10 Small-Cap Scores — March 2026
The 10 highest-scoring small-caps from March 2026, ranked across 8 fundamental metrics from 2,200+ stocks. Try free for 30 days.
Share Dilution: Small-Cap Return Killer
Share dilution quietly erodes your ownership in small-caps. Learn how to measure it and which stocks are worst offenders. Try free 30 days.
Debt-to-Equity: Small-Cap Hidden Risk
The debt-to-equity ratio reveals hidden leverage risk in small-caps. Learn sector benchmarks and red flags. Try free screening for 30 days.
Cash Runway: Small-Cap Survival Guide
Cash runway is the most critical survival metric for small-caps. Learn how to calculate it and spot red flags. Try free for 30 days.
Why Insider Ownership Matters
High insider ownership predicts small-cap outperformance. Learn what to look for and screen 2,200+ stocks — try free for 30 days.
Small-Cap vs Large-Cap: 2026 Allocation
Small-cap vs large-cap: which allocation wins in 2026? Data-driven analysis of returns, risk, and portfolio strategy. Try free for 30 days.
Rule of 40: Growth Stock Framework
The Rule of 40 balances growth and profitability for small-cap stocks. Learn how it works and screen growth stocks — try free for 30 days.
8 Metrics Every Small-Cap Investor Needs
8 fundamental metrics for small-cap investors: revenue growth, gross margin, cash runway, D/E, P/S, Rule of 40, and more. Try free for 30 days.
What Are Small-Cap Stocks?
What are small-cap stocks? Learn the key characteristics, risks, and how to evaluate them. Start screening 2,200+ stocks free for 30 days.